TFDA certified Jellox Biotech's 'MetaLite DX Digital Pathology Software' as SaMD

撰文GlobalBio & Investment
日期2024-01-25
EnglishFrenchGermanItalianPortugueseRussianSpanish
TFDA certified Jellox Biotech's 'MetaLite DX Digital Pathology Software' as SaMD
Big kudos to Jellox Biotech for reaching a significant regulatory milestone! TFDA certified their 'MetaLite DX Digital Pathology Software' as #SaMD (Software as Medical Device) this month, marking it the first offline usable digital pathology product in Taiwan.
 
This achievement promises a wave of successful installations of JelloX solutions in the next-gen pathology field.
 
Read more: https://news.gbimonthly.com/tw/article/show.php?num=64186
 
Follow #Globalbio for more groundbreaking news!
#JelloxBiotech #DigitalPathology #TFDA #TFDAApproval #MedicalInnovation